Depression, the Mood DiseaseBook - 2006
Mandimore (psychiatry, Johns Hopkins U. School of Medicine) keeps readers updated on this once-stigmatized condition, noting that even with advances in popular perceptions and improvements in diagnosis and treatment, practitioners still must exercise considerable compassion as they encounter misconceptions and fear from clients and those who care for them. He advocates a comprehensive approach which uses psychotherapy, family and community support, lifestyle changes and carefully chosen and administered medication. Coverage includes the symptoms, management, and treatment of this mood disorder, special considerations for bipolar disorder, variations in certain populations and in concert with other conditions, causal factors and associations, and the process of getting better. The references and list of support and advocacy organizations are especially helpful. Annotation ©2006 Book News, Inc., Portland, OR (booknews.com)
Johns Hopkins University Press
Depression is a mood disorder that affects one in ten Americans in any given year. At one time too stigmatized to be mentioned in polite conversation, depression is now discussed frankly in the media, and advertisements for drug therapy appear everywhere. The third edition of this widely acclaimed book reflects changes in how mood disorders are thought about, and how they are treated.
Dr. Francis Mark Mondimore, author of the best-selling book Bipolar Disorder: A Guide for Patients and Families, here explains depression—its causes and symptoms, and its treatment. He discusses depression in all age groups and in both sexes, as well as bipolar disorder, seasonal affective disorders, and depression that accompanies illness. This edition encompasses more than a decade of new research, advances in pharmacology, and changes in public perception.
The past ten years have seen the release of new forms of the major antidepressants as well as other promising new avenues in pharmaceutical treatments. For example "atypical" or "second generation" antidepressants, such as venlafaxine and duloxetine, provide different ways of manipulating the chemical systems in the brain concerned with mood. And there have been significant advances in the use of MAO inhibitors, now available in patch form.
Dr. Mondimore reviews these and other pharmacological therapies as part of a comprehensive approach to treatment that includes psychotherapy, family and community support, and lifestyle changes. Full of information compassionately presented, this guide provides hope and help to patients and their families.